FOXA1 and breast cancer: In breast cancer, FOXA1 has been shown in multiple studies to be an independent marker for good outcome (Badve et al., 2007; Hisamatsu et al., 2012); most probably because the presence of FOXA1 indicates a functional ER complex which will respond well to anti-oestrogen compounds such as Tamoxifen.